New solutions for antibiotic discovery: Prioritizing microbial biosynthetic space using ecology and machine learning
PLOS Biology · 2025
DOI: 10.1371/journal.pbio.3003058 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2025. Verfasst von Marnix H Medema und 1 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Group, Wageningen University, Wageningen, The Netherlands. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Discovery, Machine Learning. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
With the explosive increase in genome sequence data, perhaps the major challenge in natural-product-based drug discovery is the identification of gene clusters most likely to specify new chemistry and bioactivities. We discuss the challenges and state-of-the-art of antibiotic discovery based on ecological principles, genome mining and artificial intelligence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bioinformatics Group, Wageningen University, Wageningen, The Netherlands.
- Institute of Biology, Leiden University, Leiden, The Netherlands.
ORCID-Profile: Gilles P van Wezel
Zitieren
APA
Medema, M. H., & van Wezel, G. P. (2025). New solutions for antibiotic discovery: Prioritizing microbial biosynthetic space using ecology and machine learning. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003058
Vancouver
Medema MH, van Wezel GP. New solutions for antibiotic discovery: Prioritizing microbial biosynthetic space using ecology and machine learning. PLOS Biology. 2025. doi:10.1371/journal.pbio.3003058
BibTeX
@article{Medema2025,
author = {Medema, Marnix H and van Wezel, Gilles P},
title = {New solutions for antibiotic discovery: Prioritizing microbial biosynthetic space using ecology and machine learning},
journal = {PLOS Biology},
year = {2025},
doi = {10.1371/journal.pbio.3003058}
}
EUVIMED